Brain Cancer

Use of Focused Ultrasound Shows Promise for Brain Tumor Treatment

With help from an innovative clinical trial at University of Maryland Greenebaum Comprehensive Cancer Center (UMGCCC) and connected care available through University of Maryland Medical System (UMMS), a patient living on the Eastern Shore received outstanding treatment for an aggressive form of brain cancer.

New Study Reveals Reversibility of Cognitive Decline After Brain Radiation

New data shows nearly 40% of patients who experienced cognitive decline after brain radiation fully recovered within six months. Learn how targeted approaches like stereotactic radiosurgery are improving outcomes—and how this research is reshaping the way clinicians counsel patients with brain metastases about cognitive side effects.